The inhibition of free radical generation by preparations of harpagophytum procumbens in vitro

Phytotherapy Research

Volumn 23, Issue 1, 2009, Pages 104-110

  Grant, Louise ^a   McBean, Douglas E ^a   Fyfe, Lorna ^a   Warnock, A Mary ^a  

^a QUEEN MARGARET UNIVERSITY   (United Kingdom)

Author keywords

Arthritis; Devil's claw; Harpagophytum procumbens; Inflammation; Nitric oxide; Reactive nitrogen species; Reactive oxygen species; Superoxide anion

Indexed keywords

1,1 DIPHENYL 2 PICRYLHYDRAZYL; HARPAGOPHYTUM PROCUMBENS EXTRACT; MYELOPEROXIDASE; NITRITE;

ANIMAL CELL; ANTIOXIDANT ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; HARPAGOPHYTUM; HUMAN; HUMAN CELL; MACROPHAGE; MOUSE; NEUTROPHIL; NONHUMAN; PLANT ROOT; SCAVENGING SYSTEM; SUPERNATANT;

ANIMALS; ANTIOXIDANTS; CELL LINE; HARPAGOPHYTUM; HUMANS; MICE; NEUTROPHILS; NITRITES; PEROXIDASE; PICRATES; PLANT EXTRACTS; PLANT TUBERS; PLANTS, MEDICINAL; SUPEROXIDES;

ANIMALIA; HARPAGOPHYTUM PROCUMBENS;

EID: 58149510610     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.2570     Document Type: Article

References (36)

1. Babior BM. 2000. Phagocytes and oxidative stress. Am J Med 109: 33-44.
2. Betancor-Fernández A, Pérez-Gálvez A, Sies H, Stahl W. 2003. Screening pharmaceutical preparations containing extracts of turmeric rhizome, artichoke leaf, devil's claw root and garlic or salmon oil for antioxidant capacity. J Pharm Pharmacol 55: 981-986.
3. Bhattacharya A, Bhattacharya SK. 1998. Anti-oxidant activity of Harpagophytum procumbens (Devil's claw). Br J Phytother 5: 68-71.
4. Biemond P, Swaak AJ, Penders JM, Beindorff CM, Koster JF. 1986. Superoxide production by polymorphonuclear leucocytes in rheumatoid arthritis and osteoarthritis: in vivo inhibition by the antirheumatic drug piroxicam due to interference with the activation of the NADPH-oxidase. Ann Rheum Dis 45: 240-255.
5. Blois MS. 1985. Antioxidant determination by the use of a stable free radical. Nature 181: 1199-1200.
6. Boje K, Lechtenberg M, Nahrstedt A. 2003. New and known iridoid-and phenylethanoid glycosides from Harpagophytum procumbens and their in vitro inhibition of human leukocyte elastase. Planta Med 69: 820-825.
7. Bozeman PM, Learn DB, Thomas EL. 1990. Assay of the human leukocyte enzyme myeloperoxidase and eosinophil peroxidase. J Immunol Methods 126: 125-133.
8. Chapman ML, Rubin BR, Gracy RW. 1989. Increased carbonyl content of proteins in synovial fluid from patients with rheumatoid arthritis. J.Rheumatol 16: 15-18.
9. Chen ZY, Chan PT, Ho KY, Fung KP, Wang J. 1996. Antioxidant activity of natural flavonoids is governed by number and location of their aromatic hydroxyl groups. Chem Phys Lipids 79: 157-163.
10. Chrubasik S, Kunzel O, Thanner J, Conradt C, Black A. 2005. A 1-year follow-up after a pilot study with Doloteffin for low back pain. Phytomedicine 12: 1-9.
11. Chrubasik S, Model A, Black A, Pollack S. 2003. A randomized double-blind pilot study comparing Doloteffin and Vioxx in the treatment of low back pain. Rheumatology 42: 141-148.
12. Cuzzocrea S, Zingarell B, Hake P, Salzman AL, Szabó C. 1998. Antiinflammatory effects of mercaptoethylguanidine, a combined inhibitor of nitric oxide synthase and peroxynitrite scavenger in carrageenan-induced models of inflammation. Free Radic Biol Med 24: 450-459.
13. Davies KJ. 1987. Protein damage and degradation by oxygen radicals. I. General aspects. J Biol Chem 262: 9914-9920.
14. Davies KJ, Goldberg AL. 1987. Oxygen radicals stimulate intracellular proteolysis and lipid peroxidation by independent mechanisms in erythrocytes. J Biol Chem 262: 8220-8226.
15. Farrell AJ, Blake DR, Palmer RM, Moncada S. 1992. Increased concentrations of nitrite in synovial fluid and serum samples suggest increased nitric oxide synthesis in rheumatic diseases. Ann Rheum Dis 51: 1219-1222.
16. Grant L, McBean DE, Fyfe L, Warnock AM. 2005. Inhibitory effects of harpagophytum preparations on nitrite and DPPH radical. Proc Br Pharm Soc at http://www.pa2online.org/, 2/4: 56
17. Grant L, McBean DE, Fyfe L, Warnock AM. 2007. A review of the biological and potential therapeutic actions of Harpagophytum procumbens. Phytother Res 21: 199-209.
18. Huang TH-W, Tran VH, Duke RK et al. 2006. Harpagoside suppresses lipopolysaccharide-induced iNOS and COX-2 expression through inhibition of NF-kappa B activation. J Ethnopharmacol 104: 149-155.
19. Jang MH, Lim S, Han SM et al. 2003. Harpagophytum procumbens suppresses lipopolysaccharide-stimulated expressions of cyclooxygenase-2 and inducible nitric oxide synthase in fibroblast cell line L929. J Pharmacol Sci 93: 367-371.
20. Jaswal S, Mehta HC, Sood AK, Kaur J. 2003. Antioxidant status in rheumatoid arthritis and role of antioxidant therapy. Clin Chim Acta 338: 123-129.
21. Kaszkin M, Beck KF, Koch E et al. 2004. Downregulation of iNOS expression in rat mesangial cells by special extracts of Harpagophytum procumbens derives from harpagoside-dependent and independent effects. Phytomedicine 11: 585-595.
22. Langmead L, Dawson C, Hawkins C, Banna N, Loo S, Rampton DS. 2002. Antioxidant effects of herbal therapies used by patients with inflammatory bowel disease: an in vitro study. Aliment Pharmacol Ther 16: 197-205.
23. Neal TM, Vissers MC, Winterbourn CC. 1987. Inhibition of neutrophils-mediated degradation of isolated basement membrane collagen by nonsteroidal anti-inflammatory drugs that inhibit degranulation. Arthritis Rheum 30: 908-913.
24. Ohshima H, Tsuda M, Adachi H, Ogura T, Sugimura T, Esumi H. 1991. L-arginine-dependent formation of N-nitrosamines by the cytosol of macrophages activated with lipopolysac-charide and interferon-gamma. Carcinogenesis 12: 1217-1220.
25. Paredes S, Girona J, Hurt-Camejo E et al. 2002. Antioxidant vitamins and lipid peroxidation in patients with rheumatoid arthritis: association with inflammatory markers. J Rheumatol 29: 2271-2277.
26. Penn NW. 1995. Potentiation of morphine analgesic action in mice by beta-carotene. Eur J Pharmacol 284: 191-193.
27. Stefanovic-Racic M, Meyers K, Meschter C, Coffey JW, Hoffman RA, Evans CH. 1994. N-momomethyl arginine, an inhibitor of nitric oxide synthase, suppresses the development of adjuvant arthritis in rats. Arthritis Rheum 37: 1062-1069.
28. Stefanovic-Racic M, Meyers K, Meschter C, Coffey JW, Hoffman RA, Evans CH. 1995. Comparison of the nitric oxide synthase inhibitors methylarginine and aminoguanidine as prophylactic and therapeutic agents in rat adjuvant arthritis. J Rheumatol 22: 1922-1928.
29. Suzuki K, Ota H, Sasagawa S, Sakatani T, Fujikura T. 1983. Assay method for myeloperoxidase in human polymorphonuclear leukocytes. Anal Biochem 132: 345-352.
30. Talpain E, Armstrong RA, Coleman RA, Vardey CJ. 1995. Characterization of the PGE receptor subtype mediating inhibition of superoxide production in human neutrophils. Br J Pharmacol 114: 1459-1465.
31. Torsteinsdóttir I, Hâkansson L, Hällgren R, Gudbjörnsson B, Arvidson NG, Venge P. 1999. Serum lysozyme: a potential marker of monocyte/macrophage activity in rheumatoid arthritis. Rheumatology 38: 1249-1254.
32. Warnock M, McBean D, Suter A, Tan J, Whittaker P. 2007. Effectiveness and safety of Devil's Claw tablets in patients with general rheumatic disorders. Phytother Res 21: 1228-1233.
33. Weissmann G, Korchak H. 1984. Rheumatoid arthritis. The role of neutrophils activation. Inflammation 8 (Suppl): S3-S14.
34. Westacott CI, Sharif M. 1996. Cytokines in osteoarthritis: mediators or markers of joint destruction? Semin Arthritis Rheum 25: 254-272.
35. Yang JC, Pang CS, Tsang SF, Ng KF. 2001. Effect of American ginseng extract (Panax quinquefolius) on formalin-induced nociception in mice. Am J Chin Med 29: 149-154.
36. Ximenes VF, Paino IMM, de Faria-Oliveira OMM, da Fonseca LM, Brunetti IL. 2005. Indole ring oxidation by activated leukocytes prevents the production of hypochlorous acid. Braz J Med Biol Res 38: 1575-1583.